Načítá se...
Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer’s disease
BACKGROUND: Kallikrein 6 (KLK6) is known to be an age-related protease expressed at high levels in the central nervous system. It was previously shown to be involved in proteolysis of extracellular proteins implicated in neurodegenerative diseases such as Alzheimer’s disease (AD), prompting validati...
Uloženo v:
| Vydáno v: | Alzheimers Res Ther |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5789599/ https://ncbi.nlm.nih.gov/pubmed/29378650 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-018-0336-4 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|